Genpact (NYSE:G) updated its FY18 earnings guidance on Monday. The company provided earnings per share guidance of $1.70-1.74 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.77. The company issued revenue guidance of $2.93-3.00 billion, compared to the consensus revenue estimate of $2.92 billion.
A number of equities research analysts have recently commented on G shares. Cantor Fitzgerald reaffirmed a buy rating and issued a $36.00 target price on shares of Genpact in a report on Wednesday, November 8th. Robert W. Baird reaffirmed a buy rating and issued a $38.00 target price on shares of Genpact in a report on Friday, November 10th. Finally, Zacks Investment Research raised shares of Genpact from a sell rating to a hold rating and set a $35.00 target price for the company in a report on Friday, November 10th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus price target of $33.38.
Shares of Genpact (NYSE:G) traded up $0.35 during trading hours on Monday, hitting $32.30. 1,001,942 shares of the stock were exchanged, compared to its average volume of 833,867. Genpact has a 1-year low of $23.34 and a 1-year high of $34.79. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $6,167.71, a PE ratio of 23.41, a price-to-earnings-growth ratio of 1.98 and a beta of 0.57.
In other news, insider Private Ltd Gic sold 1,499,806 shares of the business’s stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $30.26, for a total transaction of $45,384,129.56. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $33.95, for a total transaction of $770,325.50. The disclosure for this sale can be found here. Insiders sold 1,660,470 shares of company stock valued at $50,598,982 over the last ninety days. Corporate insiders own 1.41% of the company’s stock.
A hedge fund recently raised its stake in Genpact stock. The Manufacturers Life Insurance Company lifted its position in shares of Genpact Limited (NYSE:G) by 7.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,508 shares of the business services provider’s stock after acquiring an additional 455 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 92.00% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/12/genpact-g-updates-fy18-earnings-guidance.html.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.